SEC Form 4 · accession 0001534122-15-000058
IRELAND INC. · IRLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas Dg Birnie
Officer — CEO, President & Secretary · Director
Period of report
May 18, 2015
Accepted (ET)
May 19, 2015 · 3:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001166338
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014 Special Warrants (Right to Buy)F1,F2 | — | May 18, 2015 | M | 375,000 | D | Mar 24, 2014 | Mar 31, 2015 | Units | 375,000 | 0 | D |
| 2015 Special Warrants (Right to Buy)F1,F3,F4,F5 | — | May 18, 2015 | M | 375,000 | A | May 18, 2015 | Feb 28, 2016 | Units | 375,000 | 625,000 | D |
Explanation of responses
- F12014 Special Warrants converted into 2015 Special Warrants pro rata to the purchase price for each ($0.20/special warrant for each).
- F2Each Unit issuable under 2014 Special Warrants consisted of one share of common stock and one share purchase warrant exercisable at $0.40 per share, expiring March 19, 2019.
- F32015 Special Warrants are convertible into Units at no extra cost on a 1:1 basis. Alternately, if the Issuer completes a Subsequent Equity Offering, holders may convert into shares of common stock or Common Stock Equivalents pro rata to the purchase price of the Subsequent Equity Offering (terms as defined in the 2015 Special Warrants).
- F42015 Special Warrants expire on the earlier of February 28, 2016 and one month after a Qualified Financing (as defined in the 2015 Special Warrants).
- F5Each Unit consists of one share of common stock and one share purchase warrant exercisable at $0.40 per share, expiring February 28, 2020.
Remarks
The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the equity securities listed in this statement for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.